Viewing Study NCT06631092


Ignite Creation Date: 2025-12-24 @ 3:15 PM
Ignite Modification Date: 2025-12-24 @ 3:15 PM
Study NCT ID: NCT06631092
Status: RECRUITING
Last Update Posted: 2025-02-04
First Post: 2024-10-02
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: Personalised Neoantigen-targeting Cancer Vaccine NECVAX-NEO1 in Neoadjuvant Triple-negative Breast Cancer
Sponsor: NEC Bio B.V
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module